FHIR © HL7.org | Server Home | FHIR Server FHIR Server 3.7.22-SNAPSHOT | FHIR Version n/a User: [n/a]

704256006: Vedolizumab (substance)

SNOMED CT Concept\Substance\...

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Immunosuppressant (substance)\Vedolizumab
\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Monoclonal antibody\Vedolizumab

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide\Protein\Antibody\Monoclonal antibody\Vedolizumab

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Polypeptide\Protein\Antibody\Monoclonal antibody\Vedolizumab

\Biological substance\Protein and/or protein derivative\Protein\Antibody\Monoclonal antibody\Vedolizumab
\Biological substance\Immunologic substance\Antibody\Monoclonal antibody\Vedolizumab
\Biological substance\Polypeptide\Protein\Antibody\Monoclonal antibody\Vedolizumab

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2015. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Vedolizumab	Is a	agent d'anticorps monoclonal	false	Inferred relationship	Some
Vedolizumab	Is a	Alpha-4 integrin receptor antagonist	true	Inferred relationship	Some
Vedolizumab	Is a	Monoclonal antibody	true	Inferred relationship	Some
Vedolizumab	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Alpha-4 integrin receptor antagonist (disposition)	true	Inferred relationship	Some
Vedolizumab	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	A substance that modifies the immune response or the functioning of the immune system.	true	Inferred relationship	Some
Vedolizumab	Is a	anticorps monoclonal chimérique souris-humain d'isotype IgG	false	Inferred relationship	Some
Vedolizumab	Is a	Immunosuppressant (substance)	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for injection (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Vedolizumab	Inferred relationship	Some
Product containing vedolizumab (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Vedolizumab	Inferred relationship	Some	1
Product containing only vedolizumab (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Vedolizumab	Inferred relationship	Some	1
Vedolizumab therapy (procedure)	Direct substance	True	Vedolizumab	Inferred relationship	Some	1
Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Vedolizumab	Inferred relationship	Some	1
Product containing precisely vedolizumab 300 milligram/1 vial powder for conventional release solution for injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Vedolizumab	Inferred relationship	Some	1
Vedolizumab-containing product in parenteral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Vedolizumab	Inferred relationship	Some	1
Product containing only vedolizumab in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Vedolizumab	Inferred relationship	Some	1
Vedolizumab 158.824 mg/mL solution for injection	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Vedolizumab	Inferred relationship	Some	1
Vedolizumab 158.824 mg/mL solution for injection	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Vedolizumab	Inferred relationship	Some	1
Vedolizumab 300 mg powder for solution for infusion vial	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Vedolizumab	Inferred relationship	Some	1
Vedolizumab 300 mg powder for solution for infusion vial	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Vedolizumab	Inferred relationship	Some	1
Vedolizumab 300 mg powder for solution for infusion and/or injection vial	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Vedolizumab	Inferred relationship	Some	1
Vedolizumab 300 mg powder for solution for infusion and/or injection vial	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Vedolizumab	Inferred relationship	Some	1

Reference Sets

Description inactivation indicator reference set

GB English

US English

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3011048012	Vedolizumab	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3011945013	Vedolizumab (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
53291000195115	vedolizumab	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
849061000172112	védolizumab	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
67461000195112	Vedolizumab	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module